buspirone has been researched along with Body Weight in 11 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In the present study, serotonin hydrochloride, buspirone (the serotonin 5-HT1A agonist) and ondensetron (the 5HT3 antagonist) were injected into nucleus caudatus through stereotaxically implanted cannulae in three different dosages (1, 2 and 5 microg) and their effects on 24 h food and water intake, and body weight were recorded." | 3.72 | Effects of injection of serotonin into nucleus caudatus on food and water intake and body weight in albino rats. ( Kannan, N; Pal, GK; Pal, P, 2004) |
| "Fluoxetine and buspirone were significantly effective in reducing rates of self-biting during treatment weeks 1 to 8 and self-directed stereotypic behavior during weeks 5 to 12 and post-treatment." | 1.33 | The effects of fluoxetine and buspirone on self-injurious and stereotypic behavior in adult male rhesus macaques. ( De Petrillo, PB; Dupuy, AM; Fontenot, MB; Higley, JD; Lynch, CR; Padgett, EE, 2005) |
| "Buspirone is a novel anti-anxiety drug which has neither a benzodiazepine structure nor any other benzodiazepine-like properties." | 1.27 | Comparative chronic effects of buspirone or neuroleptics on rat brain dopaminergic neurotransmission. ( McMillen, BA, 1985) |
| "Buspirone-treated rats gain weight during withdrawal, suggesting that this novel anxiolytic should lack dependence liability in man." | 1.27 | Lack of withdrawal signs of dependence following cessation of treatment or Ro-15,1788 administration to rats chronically treated with buspirone. ( Eison, MS, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ung, RV | 1 |
| Rouleau, P | 1 |
| Guertin, PA | 1 |
| Moncek, F | 1 |
| Duncko, R | 1 |
| Johansson, BB | 1 |
| Jezova, D | 1 |
| Fontenot, MB | 1 |
| Padgett, EE | 1 |
| Dupuy, AM | 1 |
| Lynch, CR | 1 |
| De Petrillo, PB | 1 |
| Higley, JD | 1 |
| Pal, GK | 1 |
| Kannan, N | 1 |
| Pal, P | 1 |
| Overstreet, DH | 1 |
| Knapp, DJ | 1 |
| Angel, RA | 1 |
| Navarro, M | 1 |
| Breese, GR | 1 |
| Stork, O | 1 |
| Welzl, H | 1 |
| Wolfer, D | 1 |
| Schuster, T | 1 |
| Mantei, N | 1 |
| Stork, S | 1 |
| Hoyer, D | 1 |
| Lipp, H | 1 |
| Obata, K | 1 |
| Schachner, M | 1 |
| Gao, B | 1 |
| Cutler, MG | 1 |
| McMillen, BA | 1 |
| Gilbert, F | 1 |
| Dourish, CT | 1 |
| Brazell, C | 1 |
| McClue, S | 1 |
| Stahl, SM | 1 |
| Aulakh, CS | 1 |
| Hill, JL | 1 |
| Murphy, DL | 1 |
| Eison, MS | 1 |
11 other studies available for buspirone and Body Weight
| Article | Year |
|---|---|
Functional and physiological effects of treadmill training induced by buspirone, carbidopa, and L-DOPA in clenbuterol-treated paraplegic mice.
Topics: Adipose Tissue; Analysis of Variance; Animals; Biomechanical Phenomena; Body Composition; Body Weigh | 2012 |
Effect of environmental enrichment on stress related systems in rats.
Topics: Adaptation, Physiological; Adrenal Glands; Adrenocorticotropic Hormone; Animals; Anti-Anxiety Agents | 2004 |
The effects of fluoxetine and buspirone on self-injurious and stereotypic behavior in adult male rhesus macaques.
Topics: Animals; Behavior, Animal; Body Weight; Buspirone; Cerebrospinal Fluid; Fluoxetine; Hydroxyindoleace | 2005 |
Effects of injection of serotonin into nucleus caudatus on food and water intake and body weight in albino rats.
Topics: Animals; Body Weight; Buspirone; Caudate Nucleus; Dose-Response Relationship, Drug; Drinking; Eating | 2004 |
Reduction in repeated ethanol-withdrawal-induced anxiety-like behavior by site-selective injections of 5-HT1A and 5-HT2C ligands.
Topics: Animals; Anxiety; Body Weight; Buspirone; Dose-Response Relationship, Drug; Ethanol; Ethylamines; In | 2006 |
Recovery of emotional behaviour in neural cell adhesion molecule (NCAM) null mutant mice through transgenic expression of NCAM180.
Topics: Aggression; Animals; Anti-Anxiety Agents; Anxiety; Avoidance Learning; Behavior, Animal; Body Weight | 2000 |
Effects of sub-chronic treatment with chlordiazepoxide, buspirone and the 5-HT3 receptor antagonist, BRL 46470, on the social behaviour of mice.
Topics: Animals; Body Weight; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Buspirone; | 1992 |
Comparative chronic effects of buspirone or neuroleptics on rat brain dopaminergic neurotransmission.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Anxiety Agents; Antipsychotic Agents; Body Weight; Bus | 1985 |
Relationship of increased food intake and plasma ACTH levels to 5-HT1A receptor activation in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenocorticotropic Hormone; Animals; Anti-Anxiety Agents; B | 1988 |
A comparison of feeding and locomotion responses to serotonin agonists in three rat strains.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Body Weight; Buspirone; Dose-Resp | 1988 |
Lack of withdrawal signs of dependence following cessation of treatment or Ro-15,1788 administration to rats chronically treated with buspirone.
Topics: Animals; Body Weight; Buspirone; Diazepam; Flumazenil; Food Deprivation; Male; Pyrimidines; Rats; Ra | 1986 |